🇺🇸 The triamcinolone acetonide plus ropivacaine group in United States

The triamcinolone acetonide plus ropivacaine group (The triamcinolone acetonide plus ropivacaine group) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

The triamcinolone acetonide plus ropivacaine group in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is The triamcinolone acetonide plus ropivacaine group approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for The triamcinolone acetonide plus ropivacaine group in United States?

Beijing Tiantan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.